For: | Fisher CP, Kierzek AM, Plant NJ, Moore JB. Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(41): 15070-15078 [PMID: 25386055 DOI: 10.3748/wjg.v20.i41.15070] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i41/15070.htm |
Number | Citing Articles |
1 |
Charles N. Serhan, Shailendra K. Gupta, Mauro Perretti, Catherine Godson, Eoin Brennan, Yongsheng Li, Oliver Soehnlein, Takao Shimizu, Oliver Werz, Valerio Chiurchiù, Angelo Azzi, Marc Dubourdeau, Suchi Smita Gupta, Patrick Schopohl, Matti Hoch, Dragana Gjorgevikj, Faiz M. Khan, David Brauer, Anurag Tripathi, Konstantin Cesnulevicius, David Lescheid, Myron Schultz, Eva Särndahl, Dirk Repsilber, Robert Kruse, Angelo Sala, Jesper Z. Haeggström, Bruce D. Levy, János G. Filep, Olaf Wolkenhauer. WITHDRAWN: The Atlas of Inflammation Resolution (AIR). Molecular Aspects of Medicine 2020; : 100893 doi: 10.1016/j.mam.2020.100893
|
2 |
Bruno Christ, Uta Dahmen, Karl-Heinz Herrmann, Matthias König, Jürgen R. Reichenbach, Tim Ricken, Jana Schleicher, Lars Ole Schwen, Sebastian Vlaic, Navina Waschinsky. Computational Modeling in Liver Surgery. Frontiers in Physiology 2017; 8 doi: 10.3389/fphys.2017.00906
|
3 |
Elaina M. Maldonado, Vytautas Leoncikas, Ciarán P. Fisher, J. Bernadette Moore, Nick J. Plant, Andrzej M. Kierzek. Integration of Genome Scale Metabolic Networks and Gene Regulation of Metabolic Enzymes With Physiologically Based Pharmacokinetics. CPT: Pharmacometrics & Systems Pharmacology 2017; 6(11): 732 doi: 10.1002/psp4.12230
|
4 |
Yaqi Lu, Wangxian Tang, Heng Zhang, Jing Liu, Shan Zhong, De'Broski R. Herbert.
Effect of hepatocyte damage in hepatic fibrogenesis of patients infected with
Schistosoma japonicum
. Infection and Immunity 2024; 92(6) doi: 10.1128/iai.00026-24
|
5 |
Charles N. Serhan, Shailendra K. Gupta, Mauro Perretti, Catherine Godson, Eoin Brennan, Yongsheng Li, Oliver Soehnlein, Takao Shimizu, Oliver Werz, Valerio Chiurchiù, Angelo Azzi, Marc Dubourdeau, Suchi Smita Gupta, Patrick Schopohl, Matti Hoch, Dragana Gjorgevikj, Faiz M. Khan, David Brauer, Anurag Tripathi, Konstantin Cesnulevicius, David Lescheid, Myron Schultz, Eva Särndahl, Dirk Repsilber, Robert Kruse, Angelo Sala, Jesper Z. Haeggström, Bruce D. Levy, János G. Filep, Olaf Wolkenhauer. The Atlas of Inflammation Resolution (AIR). Molecular Aspects of Medicine 2020; 74: 100894 doi: 10.1016/j.mam.2020.100894
|
6 |
Fenni Rusli, Carolien Lute, Mark V. Boekschoten, Miriam van Dijk, Klaske van Norren, Aswin L. Menke, Michael Müller, Wilma T. Steegenga. Intermittent calorie restriction largely counteracts the adverse health effects of a moderate‐fat diet in aging C57BL/6J mice. Molecular Nutrition & Food Research 2017; 61(5) doi: 10.1002/mnfr.201600677
|
7 |
Cene Skubic, Živa Drakulić, Damjana Rozman. Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(8): 831 doi: 10.1080/17425255.2018.1492552
|
8 |
J. Bernadette Moore. From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis. Proceedings of the Nutrition Society 2019; 78(3): 290 doi: 10.1017/S0029665119000570
|
9 |
J. Bernadette Moore. From personalised nutrition to precision medicine: the rise of consumer genomics and digital health. Proceedings of the Nutrition Society 2020; 79(3): 300 doi: 10.1017/S0029665120006977
|
10 |
Anchal Rana, Kiran Thakur, Meenakshi Thakur. Innovative Methods in Horticultural Crop Improvement. Advances in Plant Breeding Strategies 2024; 2: 237 doi: 10.1007/978-3-031-61095-0_9
|
11 |
Fareeha Azam, Nadeem Sheikh, Gibran Ali, Asima Tayyeb. Fagonia indica Repairs Hepatic Damage through Expression Regulation of Toll-Like Receptors in a Liver Injury Model. Journal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/7967135
|
12 |
George V. Dedoussis, Athina I. Amanatidou. NAFLD and NASH. 2020; : 181 doi: 10.1007/978-3-030-37173-9_10
|
13 |
S. AlGhamdi, V. Leoncikas, K. E. Plant, N. J. Plant. Synergistic interaction between lipid-loading and doxorubicin exposure in Huh7 hepatoma cells results in enhanced cytotoxicity and cellular oxidative stress: implications for acute and chronic care of obese cancer patients. Toxicology Research 2015; 4(6): 1479 doi: 10.1039/C5TX00173K
|
14 |
Jim Bosley, Christofer Boren, Sunjae Lee, Morten Grøtli, Jens Nielsen, Mathias Uhlen, Jan Boren, Adil Mardinoglu. Improving the economics of NASH/NAFLD treatment through the use of systems biology. Drug Discovery Today 2017; 22(10): 1532 doi: 10.1016/j.drudis.2017.07.005
|
15 |
Ronja Lea Jennifer Müller, Céline Cavallo, Suchi Smita Gupta, Matti Hoch, Shailendra Gupta. Inflammation Resolution and Chronic Diseases. 2024; : 285 doi: 10.1007/978-981-97-0157-5_13
|
16 |
Nádia Araújo Miguel, Silvia Franco Andrade, Gisele Nai, Cecília Braga Laposy, Felipe Franco Nascimento, Heloise Rangel Dinallo, Alessandra Melchert. EFFECTS OF RESVERATROL ON LIVER FUNCTION OF OBESE FEMALE WISTAR RATS. Ciência Animal Brasileira 2016; 17(3): 402 doi: 10.1590/1089-6891v17i332990
|
17 |
J. Moore, Pippa Gunn, Barbara Fielding. The Role of Dietary Sugars and De novo Lipogenesis in Non-Alcoholic Fatty Liver Disease. Nutrients 2014; 6(12): 5679 doi: 10.3390/nu6125679
|
18 |
Ming-Yang Tsai, Wei-Cheng Yang, Chuen-Fu Lin, Chao-Min Wang, Hsien-Yueh Liu, Chen-Si Lin, Jen-Wei Lin, Wei-Li Lin, Tzu-Chun Lin, Pei-Shan Fan, Kuo-Hsiang Hung, Yu-Wen Lu, Geng-Ruei Chang. The Ameliorative Effects of Fucoidan in Thioacetaide-Induced Liver Injury in Mice. Molecules 2021; 26(7): 1937 doi: 10.3390/molecules26071937
|
19 |
Joost Boeckmans, Alessandra Natale, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim M. Rodrigues. Human-based systems: Mechanistic NASH modelling just around the corner?. Pharmacological Research 2018; 134: 257 doi: 10.1016/j.phrs.2018.06.029
|
20 |
Elaina M. Maldonado, Ciarán P. Fisher, Dawn J. Mazzatti, Amy L. Barber, Marcus J. Tindall, Nicholas J. Plant, Andrzej M. Kierzek, J. Bernadette Moore. Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver disease. npj Systems Biology and Applications 2018; 4(1) doi: 10.1038/s41540-018-0070-3
|